Syrentis Clinical Research

Syrentis Clinical Research is a multi-specialty clinical research site based in Santa Ana, California, specializing in central nervous system (CNS) disorders, particularly Alzheimer's disease and dementia. Founded in 2013 after acquiring the Apex Research Institute, the center conducts Phase 2 through Phase 4 clinical trials in collaboration with major pharmaceutical sponsors and CROs. In addition to its primary focus on memory loss and neurodegenerative diseases, Syrentis conducts trials for depression, anxiety, ADHD, Tourette syndrome, and cardiovascular and dermatological conditions. The facility provides comprehensive clinical trial management, patient recruitment, and regulatory oversight to advance novel therapeutic candidates.